One of the most prominent examples of lncRNAs in clinical practice is also PCA3 (Prostate Cancer Antigen 3), an FDA-approved biomarker for prostate cancer diagnosis, which outperforms traditional PSA testing in specificity [116]. The gene discussed is PCA3; the disease is prostate carcinoma.